isabelobrien, Author at European Medical Journal - Page 48 of 66

Going the extra mile for women's health

How can pharma boost R&D efforts into women’s health issues?

Decentralised clinical trials: going green

Decentralised clinical trials are held in high regard in terms of climate impact, but are they as sustainable as they seem?

Tackling the trust gap in genomic medicine

How can pharma tackle public mistrust in genomic medicine?

Reframing pharma's bad boy reputation

The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?

Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

Pharma's next move in the online jungle

What lies in wait for pharma in the social media jungle?

Bolstering data ownership with blockchain

Blockchain allow patients to own their data and better protects their personal information. How could it change the data landscape in pharma?

Pharma in India

India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?

Are MSLs ready for the spotlight?

How can the industry empower MSLs as they do sales reps?

A pandemic response in 100 days

This infographic looks at the mission to make an effective vaccine against any virus in just 100 days and explores the diseases that are re-emerging that could be combatted with an expedited approach.